Scientist Release ‘Smoking Gun’ Details About AstraZeneca Jab

A major report about the AstraZeneca vaccine has found the “smoking gun” link causing lethal blood clots.

Censorship in this day and age is a real thing so we are going to post excerpts from The Telegraph report that was posted by MSN. Several other news outlets have also reported the authenticity of the study.

Scientists at Cardiff University claim they have discovered a protein in the blood that is causing the dangerous clotting.

According to researchers, a protein called “platelet factor four” acts like a magnet.

From The Telegraph:

The new study shows that adenovirus attracts a protein called “platelet factor four” to it like a magnet.

This new hybrid protein-virus confuses the immune system, which creates new antibodies, which themselves stick to the proteins, triggering the formation of dangerous blood clots.

The process happens only rarely, explaining why few people are affected by the condition.

The clots have been linked to 73 deaths out of 50 million doses of AstraZeneca in the UK.

Cardiff University received government funding to discover what was causing the clotting. Researchers soon realised that people suffering clots had extra antibodies that were attacking “platelet factor four”.

A spokeswoman for AstraZeneca did not deny the report.

“Although the research is not definitive, it offers interesting insights and AstraZeneca is exploring ways to leverage these findings as part of our efforts to remove this extremely rare side effect,” a spokeswoman said.

More from the Telegraph:

Professor Alan Parker, one of the researchers at Cardiff University, told BBC News: “The adenovirus has an extremely negative surface, and platelet factor four is extremely positive and the two things fit together quite well.”

He added: “We’ve been able to prove the link between the key smoking guns of adenoviruses and platelet factor four.

“What we have is the trigger, but there’s a lot of steps that have to happen next.”

In the UK the AstraZeneca vaccine is not offered to people under 40 because of the risks.

The Telegraph